Relpax and Nitrostat drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Relpax (eletriptan hydrobromide) and Nitrostat (nitroglycerin). Common drug interactions include headache among females.

The phase IV clinical study analyzes what interactions people have when they take Relpax and Nitrostat. It is created by eHealthMe based on reports of 27 people who take the same drugs from the FDA, and is updated regularly.

What is Relpax?

Relpax has active ingredients of eletriptan hydrobromide. It is often used in migraine. eHealthMe is studying from 9,259 Relpax users. Check the latest studies of Relpax.

What is Nitrostat?

Nitrostat has active ingredients of nitroglycerin. It is often used in chest pain. eHealthMe is studying from 14,082 Nitrostat users. Check the latest studies of Nitrostat.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

27 people who take Relpax and Nitrostat together, and have interactions are studied.

What are the common drug interactions of Relpax and Nitrostat, by gender? *:

female:

Headache (pain in head)
Central nervous system lesion (an abnormality in tissue of brain or spinal cord)
Memory impairment
Neoplasm malignant (cancer tumour)
Neuropathy peripheral (surface nerve damage)
Non-hodgkin's lymphoma (malignant (cancer) cells form in the lymph system)
Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
Urinary retention (the inability to completely or partially empty the bladder)
Vision blurred
Weight decreased

male:

n/a

What are the common drug interactions of Relpax and Nitrostat, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Central nervous system lesion (an abnormality in tissue of brain or spinal cord)
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Cerebrovascular disorder (disease of brain)
Confusional state
Depressed mood
Diplopia (double vision)
Disturbance in attention
Fall
Gammopathy (abnormal proliferation of the lymphoid cells producing immunoglobulins)
Headache (pain in head)

60+:

Pain
Chronic kidney disease
Cystitis (inflammation of the wall of the bladder)
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Nephrolithiasis (calculi in the kidneys)
Osteomalacia (softening of the bones due to a lack of vitamin d)
Renal tubular necrosis (death of kidney tubules)
Blood cholesterol increased
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Drug hypersensitivity

What are the existing conditions these people have? *

Depression: 16 people, 59.26%
Stress And Anxiety: 15 people, 55.56%
Pain: 15 people, 55.56%
Nausea (feeling of having an urge to vomit): 14 people, 51.85%
Thyroid Diseases: 12 people, 44.44%
Neuralgia (pain in one or more nerves): 12 people, 44.44%
Neuropathy Peripheral (surface nerve damage): 11 people, 40.74%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 11 people, 40.74%
Diarrhea: 11 people, 40.74%
Asthma: 9 people, 33.33%

* Approximation only. Some reports may have incomplete information.

Do you take Relpax and Nitrostat?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously